Bone Metabolism in Inflammatory Bowel Disease and Celiac Disease

1.

Briot K, Geusens P, Em Bultink I, Lems WF, Roux C. Inflammatory diseases and bone fragility. Osteoporos Int. 2017;28(12):3301–14.

CAS  PubMed  Google Scholar 

2.

Oh HJ, Ryu KH, Park BJ, Yoon BH. Osteoporosis and osteoporotic fractures in gastrointestinal disease. J Bone Metab. 2018;25(4):213–7.

PubMed  PubMed Central  Google Scholar 

3.

Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, et al. The impact of inflammatory bowel disease in Canada 2018: extra-intestinal diseases in IBD. J Can Assoc Gastroenterol. 2019;2(Suppl 1):S73–80.

PubMed  Google Scholar 

4.

Chedid VG, Kane SV. Bone health in patients with inflammatory bowel diseases. J Clin Densitom. 2019.

5.

Gastroenterology BSo, Lewis N, Scott BB. Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease: British society of Gastroenterology; 2008.

6.

Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017;112(2):241–58.

PubMed  Google Scholar 

7.

Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(3):239–54.

PubMed  Google Scholar 

8.

Adriani A, Pantaleoni S, Luchino M, Ribaldone DG, Reggiani S, Sapone N, et al. Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease. Panminerva Med. 2014;56(2):145–9.

CAS  PubMed  Google Scholar 

9.

Szafors P, Che H, Barnetche T, Morel J, Gaujoux-Viala C, Combe B, et al. Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis. Osteoporos Int. 2018;29(11):2389–97.

CAS  PubMed  Google Scholar 

10.

Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med. 2009;122(7):599–604.

PubMed  PubMed Central  Google Scholar 

11.

Schule S, Rossel JB, Frey D, Biedermann L, Scharl M, Zeitz J, et al. Prediction of low bone mineral density in patients with inflammatory bowel diseases. United European Gastroenterol J. 2016;4(5):669–76.

PubMed  PubMed Central  Google Scholar 

12.

Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology. 1994;107(4):1031–9.

CAS  PubMed  Google Scholar 

13.

Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133(10):795–9.

CAS  Google Scholar 

14.

Card T, West J, Hubbard R, Logan RF. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut. 2004;53(2):251–5.

CAS  PubMed  PubMed Central  Google Scholar 

15.

van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology. 2003;125:15917.

Google Scholar 

16.

Loftus EV Jr, Crowson CS, Sandborn WJ, Tremaine WJ, O'Fallon WM, Melton LJ 3rd. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology. 2002;123(2):468–75.

PubMed  Google Scholar 

17.

Vestergaard P. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med. 2004;95(6):469–80.

CAS  PubMed  Google Scholar 

18.

Ludvigsson JF, Mahl M, Sachs MC, Bjork J, Michaelsson K, Ekbom A, et al. Fracture risk in patients with inflammatory bowel disease: a Nationwide population-based cohort study from 1964 to 2014. Am J Gastroenterol. 2019;114(2):291–304.

PubMed  Google Scholar 

19.

Even Dar R, Mazor Y, Karban A, Ish-Shalom S, Segal E. Risk factors for low bone density in inflammatory bowel disease: use of glucocorticoids, low body mass index, and smoking. Dig Dis. 2019;37(4):284–90.

PubMed  Google Scholar 

20.

van Hogezand RA, Hamdy NA. Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl. 2006:59–64.

21.

Gupta S, Wu X, Moore T, Shen B. Frequency, risk factors, and adverse sequelae of bone loss in patients with ostomy for inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20(2):259–64.

PubMed  Google Scholar 

22.

Ezzat Y, Hamdy K. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases. Int J Rheum Dis. 2010;13(3):259–65.

PubMed  Google Scholar 

23.

Naito T, Yokoyama N, Kakuta Y, Ueno K, Kawai Y, Onodera M, et al. Clinical and genetic risk factors for decreased bone mineral density in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2018;33(11):1873–81.

CAS  PubMed  Google Scholar 

24.

Adamopoulos IE. Inflammation in bone physiology and pathology. Curr Opin Rheumatol. 2018;30(1):59–64.

CAS  PubMed  PubMed Central  Google Scholar 

25.

Tilg H, Moschen AR, Kaser A, Pines A, Dotan I. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut. 2008;57(5):684–94.

CAS  PubMed  Google Scholar 

26.

Schulte CM, Dignass AU, Goebell H, Roher HD, Schulte KM. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology. 2000;119(4):909–20.

CAS  PubMed  Google Scholar 

27.

Cleynen I, Gonzalez JR, Figueroa C, Franke A, McGovern D, Bortlik M, et al. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European project. Gut. 2013;62(11):1556–65.

CAS  PubMed  Google Scholar 

28.

Brinar M, Vermeire S, Cleynen I, Lemmens B, Sagaert X, Henckaerts L, et al. Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients. J Crohns Colitis. 2012;6(1):43–50.

PubMed  Google Scholar 

29.

Schulte C, Goebell H, Roher HD, Schulte KM. Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease. Dig Dis Sci. 2001;46(11):2521–8.

CAS  PubMed  Google Scholar 

30.

Krela-Kazmierczak I, Kaczmarek-Rys M, Szymczak A, Michalak M, Skrzypczak-Zielinska M, Drweska-Matelska N, et al. Bone metabolism and the c.-223C > T polymorphism in the 5'UTR region of the Osteoprotegerin gene in patients with inflammatory bowel disease. Calcif Tissue Int. 2016;99(6):616–24.

CAS  PubMed  PubMed Central  Google Scholar 

31.

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599–603.

CAS  PubMed  Google Scholar 

32.

Szymczak-Tomczak A, Krela-Kazmierczak I, Kaczmarek-Rys M, Hryhorowicz S, Stawczyk-Eder K, Szalata M, et al. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases. Adv Clin Exp Med. 2019;28:975–80.

Google Scholar 

33.

Robinson RJ, Iqbal SJ, Al-Azzawi F, Abrams K, Mayberry JF. Sex hormone status and bone metabolism in men with Crohn's disease. Aliment Pharmacol Ther. 1998;12(1):21–5.

CAS  Google Scholar 

34.

Miznerova E, Hlavaty T, Koller T, Toth J, Holociova K, Huorka M, et al. The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease. Bratisl Lek Listy. 2013;114(8):439–45.

CAS  PubMed  Google Scholar 

35.

Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari F, Letourneau N, et al. Pregnant women with inflammatory bowel disease are at increased risk of vitamin D insufficiency: a cross-sectional study. J Crohns Colitis. 2018;12(6):702–9.

PubMed  PubMed Central  Google Scholar 

36.

Gilman J, Shanahan F, Cashman KD. Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr. 2006;60(7):889–96.

CAS  PubMed  Google Scholar 

37.

Nielsen OH, Rejnmark L, Moss AC. Role of vitamin D in the natural history of inflammatory bowel disease. J Crohns Colitis. 2018;12(6):742–52.

PubMed  Google Scholar 

38.

Limketkai BN, Mullin GE, Limsui D, Parian AM. Role of vitamin D in inflammatory bowel disease. Nutr Clin Pract. 2017;32(3):337–45.

CAS  PubMed  Google Scholar 

39.

Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011;35(3):308–16.

CAS  PubMed  Google Scholar 

40.

Rodriguez-Bores L, Barahona-Garrido J, Yamamoto-Furusho JK. Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol. 2007;13(46):6156–65.

CAS  PubMed  PubMed Central  Google Scholar 

41.

Buckley L, Humphrey MB. Glucocorticoid-induced osteoporosis. N Engl J Med. 2018;379(26):2547–56.

PubMed  Google Scholar 

42.

Sylvester FA. Inflammatory bowel disease: effects on bone and mechanisms. Adv Exp Med Biol. 2017;1033:133–50.

CAS  PubMed  Google Scholar 

43.

Maldonado-Perez MB, Castro-Laria L, Caunedo-Alvarez A, Montoya-Garcia MJ, Giner-Garcia M, Arguelles-Arias F, et al. Does the antitumor necrosis factor-alpha therapy decrease the vertebral fractures occurrence in inflammatory bowel disease? J Clin Densitom. 2019;22(2):195–202.

CAS  PubMed  Google Scholar 

44.

Castro B, Rivero M, Crespo J, Riancho JA, Valero C. Influence of anti-TNF therapy on bone metabolism in patients with inflammatory bowel disease. Eur J Intern Med. 2017;39:e33–e4.

CAS  PubMed  Google Scholar 

45.

Hakimian S, Kheder J, Arum S, Cave DR, Hyatt B. Re-evaluating osteoporosis and fracture risk in Crohn's disease patients in the era of TNF-alpha inhibitors. Scand J Gastroenterol. 2018;53(2):168–72.

CAS  PubMed  Google Scholar 

46.

Veerappan SG, O'Morain CA, Daly JS, Ryan BM. Review article: the effects of antitumour necrosis factor-alpha on bone metabolism in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33(12):1261–72.

CAS  PubMed  Google Scholar 

47.

Franchimont N, Putzeys V, Collette J, Vermeire S, Rutgeerts P, De Vos M, et al. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther. 2004;20(6):607–14.

留言 (0)

沒有登入
gif